BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 23547709)

  • 41. Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells.
    You D; Jung SP; Jeong Y; Bae SY; Lee JE; Kim S
    BMB Rep; 2017 Dec; 50(12):615-620. PubMed ID: 28855026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dependency of Tamoxifen Sensitive and Resistant ER
    Bhasin S; Dusek C; Peacock JW; Cherkasov A; Wang Y; Gleave M; Ong CJ
    Cells; 2023 Jun; 12(13):. PubMed ID: 37443749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
    Watanabe T; Oba T; Tanimoto K; Shibata T; Kamijo S; Ito KI
    PLoS One; 2021; 16(6):e0252822. PubMed ID: 34101751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of β-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line.
    Won HS; Lee KM; Oh JE; Nam EM; Lee KE
    PLoS One; 2016; 11(5):e0155983. PubMed ID: 27196739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sox2 promotes tamoxifen resistance in breast cancer cells.
    Piva M; Domenici G; Iriondo O; Rábano M; Simões BM; Comaills V; Barredo I; López-Ruiz JA; Zabalza I; Kypta R; Vivanco Md
    EMBO Mol Med; 2014 Jan; 6(1):66-79. PubMed ID: 24178749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties.
    Lin X; Li J; Yin G; Zhao Q; Elias D; Lykkesfeldt AE; Stenvang J; Brünner N; Wang J; Yang H; Bolund L; Ditzel HJ
    Breast Cancer Res; 2013 Dec; 15(6):R119. PubMed ID: 24355041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer.
    Wu X; Zahari MS; Renuse S; Nirujogi RS; Kim MS; Manda SS; Stearns V; Gabrielson E; Sukumar S; Pandey A
    Mol Cell Proteomics; 2015 Nov; 14(11):2887-900. PubMed ID: 26330541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
    Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
    Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy.
    Elias D; Vever H; Lænkholm AV; Gjerstorff MF; Yde CW; Lykkesfeldt AE; Ditzel HJ
    Oncogene; 2015 Apr; 34(15):1919-27. PubMed ID: 24882577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of monocarboxylate transporter I/lactate dehydrogenase B-mediated lactate recycling in tamoxifen-resistant breast cancer cells.
    Choi MC; Kim SK; Choi YJ; Choi YJ; Kim S; Jegal KH; Lim SC; Kang KW
    Arch Pharm Res; 2023 Dec; 46(11-12):907-923. PubMed ID: 38048029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulation of SOX11 enhances tamoxifen resistance and promotes epithelial-to-mesenchymal transition via slug in MCF-7 breast cancer cells.
    Xiao Y; Xie Q; Qin Q; Liang Y; Lin H; Zeng D
    J Cell Physiol; 2020 Oct; 235(10):7295-7308. PubMed ID: 32043610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-canonical AR activity facilitates endocrine resistance in breast cancer.
    Chia K; Milioli H; Portman N; Laven-Law G; Coulson R; Yong A; Segara D; Parker A; Caldon CE; Deng N; Swarbrick A; Tilley WD; Hickey TE; Lim E
    Endocr Relat Cancer; 2019 Feb; 26(2):251-264. PubMed ID: 30557851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ceramide kinase confers tamoxifen resistance in estrogen receptor-positive breast cancer by altering sphingolipid metabolism.
    Huang C; Su L; Chen Y; Wu S; Sun R; Xu Q; Qiu X; Yang C; Kong X; Qin H; Zhao X; Jiang X; Wang K; Zhu Y; Wong PP
    Pharmacol Res; 2023 Jan; 187():106558. PubMed ID: 36410675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer.
    Ward A; Balwierz A; Zhang JD; Küblbeck M; Pawitan Y; Hielscher T; Wiemann S; Sahin Ö
    Oncogene; 2013 Feb; 32(9):1173-82. PubMed ID: 22508479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Lim SC; Kim HS; Kim TH; Lee KY; Ahn SG; Yoon JH; Kang KW
    Breast Cancer Res Treat; 2011 Nov; 130(1):73-83. PubMed ID: 21170675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.
    Cui J; Yang Y; Li H; Leng Y; Qian K; Huang Q; Zhang C; Lu Z; Chen J; Sun T; Wu R; Sun Y; Song H; Wei X; Jing P; Yang X; Zhang C
    Oncogene; 2015 Jul; 34(30):3895-907. PubMed ID: 25531331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.
    Zhou C; Zhong Q; Rhodes LV; Townley I; Bratton MR; Zhang Q; Martin EC; Elliott S; Collins-Burow BM; Burow ME; Wang G
    Breast Cancer Res; 2012 Mar; 14(2):R45. PubMed ID: 22417809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
    Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
    Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.
    Lindberg K; Helguero LA; Omoto Y; Gustafsson JÅ; Haldosén LA
    Breast Cancer Res; 2011 Apr; 13(2):R43. PubMed ID: 21492444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tamoxifen-resistant breast cancer cells possess cancer stem-like cell properties.
    Liu H; Zhang HW; Sun XF; Guo XH; He YN; Cui SD; Fan QX
    Chin Med J (Engl); 2013 Aug; 126(16):3030-4. PubMed ID: 23981606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.